ARTICLE | Clinical News
Medarex starts prostate cancer Phase II
June 23, 2004 7:00 AM UTC
MEDX began a dose-escalation Phase II trial of MDX-070 in up to 30 patients with hormone-refractory prostate cancer. The trial will assess tumor response based on objective tumor response and decrease...